Generalized myasthenia gravis is a chronic autoimmune disorder characterized by an attack on the structures of the neuromuscular junction and by fluctuating muscle weakness and pathological fatigue, involving the ocular, bulbar, respiratory and skeletal muscles. Modern treatment of generalized myasthenia gravis aims to...
O. Boyko, T. Alekseeva, O. Gilvanova et al.· Neurology, neuropsychiatry,...· 0 citations
Introduction Early differential diagnosis of acute cerebrovascular events remains a key clinical challenge, particularly during the hyperacute phase. This study aimed to assess plasma amino acid profiles and their dynamic changes as potential biomarkers and to evaluate their contribution to diagnostic accuracy. Methods...
S. Battakova, M. Grigolashvili, D. Klyuyev et al.· Frontiers in Neurology· 0 citations
The findings confirm the significant role of polymorphisms in the IL6, SIRT1 and MMP9 genes as potential genetic markers of an increased risk of developing MS and NMOSD in the studied population.
D. Kasatkin, A. Menshikh, O. D. Samoilova et al.· Neurology, neuropsychiatry,...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.